GW Pharmaceuticals Beats CBD Patent Infringement Suit
A Texas federal judge has tossed Canopy Growth Corp.'s claims against GW Pharmaceuticals PLC units for allegedly infringing its patented extraction process to make the flagship CBD drug Epidiolex, after the...To view the full article, register now.
Already a subscriber? Click here to view full article